NEA Management Company’s Marker Therapeutics MRKR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.49M | Hold |
1,625,678
| – | – | 0.19% | 28 |
|
2025
Q1 | $2M | Hold |
1,625,678
| – | – | 0.15% | 33 |
|
2024
Q4 | $5.06M | Buy |
1,625,678
+554,250
| +52% | +$1.72M | 0.29% | 32 |
|
2024
Q3 | $3.02M | Hold |
1,071,428
| – | – | 0.16% | 36 |
|
2024
Q2 | $5.82M | Hold |
1,071,428
| – | – | 0.44% | 33 |
|
2024
Q1 | $4.61M | Hold |
1,071,428
| – | – | 0.29% | 37 |
|
2023
Q4 | $5.89M | Hold |
1,071,428
| – | – | 0.39% | 33 |
|
2023
Q3 | $4.86M | Hold |
1,071,428
| – | – | 0.38% | 34 |
|
2023
Q2 | $3.32M | Hold |
1,071,428
| – | – | 0.25% | 36 |
|
2023
Q1 | $761K | Sell |
1,071,428
-1
| -0% | -$1 | 0.05% | 46 |
|
2022
Q4 | $2.85M | Hold |
1,071,429
| – | – | 0.16% | 43 |
|
2022
Q3 | $3.95M | Hold |
1,071,429
| – | – | 0.2% | 47 |
|
2022
Q2 | $3.54M | Hold |
1,071,429
| – | – | 0.18% | 49 |
|
2022
Q1 | $4.71M | Hold |
1,071,429
| – | – | 0.14% | 50 |
|
2021
Q4 | $10.2M | Hold |
1,071,429
| – | – | 0.21% | 45 |
|
2021
Q3 | $18.1M | Hold |
1,071,429
| – | – | 0.22% | 41 |
|
2021
Q2 | $29.9M | Hold |
1,071,429
| – | – | 0.39% | 35 |
|
2021
Q1 | $24M | Buy |
1,071,429
+571,429
| +114% | +$12.8M | 0.54% | 36 |
|
2020
Q4 | $7.25M | Hold |
500,000
| – | – | 0.19% | 51 |
|
2020
Q3 | $7.5M | Hold |
500,000
| – | – | 0.32% | 42 |
|
2020
Q2 | $10.4M | Hold |
500,000
| – | – | 0.42% | 31 |
|
2020
Q1 | $9.5M | Hold |
500,000
| – | – | 0.5% | 30 |
|
2019
Q4 | $14.4M | Hold |
500,000
| – | – | 0.68% | 25 |
|
2019
Q3 | $25.6M | Hold |
500,000
| – | – | 2.12% | 14 |
|
2019
Q2 | $39.6M | Hold |
500,000
| – | – | 2.77% | 13 |
|
2019
Q1 | $33M | Hold |
500,000
| – | – | 1.71% | 16 |
|
2018
Q4 | $27.8M | Buy |
+500,000
| New | +$27.8M | 1.1% | 18 |
|